Status:
COMPLETED
Bariatric Surgery on obesity-and Diabetes-associated Abnormalities of Hemostasis, Inflammation and Vascular Function.
Lead Sponsor:
Ersta Diakoni
Collaborating Sponsors:
Karolinska Institutet
Conditions:
Surgery
Obesity Associated Disorder
Eligibility:
All Genders
18-70 years
Phase:
NA
Brief Summary
The goal of this prospective cohort study is to examine circulating biomarkers before and after weight loss in patients with obesity, with or without concomitant diabetes, undergoing bariatric surgery...
Detailed Description
In this single centre, prospective, parallel group, cohort study, patients meeting the eligibility criteria are recruited at the department of surgery at Ersta hospital, Stockholm, Sweden. Patients wi...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- Age 18-70 years old
- Planned for Roux-en-y gastric bypass surgery
- Obesity fulfilling criteria for bariatric surgery (according to the European Association for the Study of Obesity guidelines, ref. Yumuk et al. European Guidelines for Obesity Management in Adults. Obes Facts 2015;8:402-42.)
- Exclusion criteria:
- Ongoing treatment with anticoagulant medication
- Ongoing treatment with antiplatelet medication other than acetylsalicylic acid
- Type 1 diabetes
Exclusion
Key Trial Info
Start Date :
January 1 2015
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2022
Estimated Enrollment :
61 Patients enrolled
Trial Details
Trial ID
NCT06071559
Start Date
January 1 2015
End Date
June 1 2022
Last Update
October 6 2023
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.